According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.39 B. In 2022 the company made a revenue of $75.42 M an increase over the years 2021 revenue that were of $66.56 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.39 B | 425.83% |
2022 | $75.42 M | 13.31% |
2021 | $66.56 M | -73.44% |
2020 | $0.25 B | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |